Cargando…

Species-Specific Differences in the Susceptibility of Fungi to the Antifungal Protein AFP Depend on C-3 Saturation of Glycosylceramides

AFP is an antimicrobial peptide (AMP) produced by the filamentous fungus Aspergillus giganteus and is a very potent inhibitor of fungal growth that does not affect the viability of bacteria, plant, or mammalian cells. It targets chitin synthesis and causes plasma membrane permeabilization in many hu...

Descripción completa

Detalles Bibliográficos
Autores principales: Paege, Norman, Warnecke, Dirk, Zäuner, Simone, Hagen, Silke, Rodrigues, Ana, Baumann, Birgit, Thiess, Melanie, Jung, Sascha, Meyer, Vera
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6908424/
https://www.ncbi.nlm.nih.gov/pubmed/31826973
http://dx.doi.org/10.1128/mSphere.00741-19
_version_ 1783478721222541312
author Paege, Norman
Warnecke, Dirk
Zäuner, Simone
Hagen, Silke
Rodrigues, Ana
Baumann, Birgit
Thiess, Melanie
Jung, Sascha
Meyer, Vera
author_facet Paege, Norman
Warnecke, Dirk
Zäuner, Simone
Hagen, Silke
Rodrigues, Ana
Baumann, Birgit
Thiess, Melanie
Jung, Sascha
Meyer, Vera
author_sort Paege, Norman
collection PubMed
description AFP is an antimicrobial peptide (AMP) produced by the filamentous fungus Aspergillus giganteus and is a very potent inhibitor of fungal growth that does not affect the viability of bacteria, plant, or mammalian cells. It targets chitin synthesis and causes plasma membrane permeabilization in many human- and plant-pathogenic fungi, but its exact mode of action is not known. After adoption of the “damage-response framework of microbial pathogenesis” regarding the analysis of interactions between AMPs and microorganisms, we have recently proposed that the cytotoxic capacity of a given AMP depends not only on the presence/absence of its target(s) in the host and the AMP concentration applied but also on other variables, such as microbial survival strategies. We show here using the examples of three filamentous fungi (Aspergillus niger, Aspergillus fumigatus, and Fusarium graminearum) and two yeasts (Saccharomyces cerevisiae and Pichia pastoris) that the important parameters defining the AFP susceptibilities of these fungi are (i) the presence/absence of glycosylceramides, (ii) the presence/absence of Δ3(E) desaturation of the fatty acid chain therein, and (iii) the (dis)ability of these fungi to respond to AFP inhibitory effects with the fortification of their cell walls via increased chitin and β-(1,3)-glucan synthesis. These observations support the idea of the adoption of the damage-response framework to holistically understand the outcome of AFP inhibitory effects. IMPORTANCE Our data suggest a fundamental role of glycosylceramides in the susceptibility of fungi to AFP. We discovered that only a minor structural difference in these molecules—namely, the saturation level of their fatty acid chain, controlled by a 2-hydroxy fatty N-acyl-Δ3(E)-desaturase—represents a key to understanding the inhibitory activity of AFP. As glycosylceramides are important components of fungal plasma membranes, we propose a model which links AFP-mediated inhibition of chitin synthesis in fungi with its potential to disturb plasma membrane integrity.
format Online
Article
Text
id pubmed-6908424
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher American Society for Microbiology
record_format MEDLINE/PubMed
spelling pubmed-69084242019-12-16 Species-Specific Differences in the Susceptibility of Fungi to the Antifungal Protein AFP Depend on C-3 Saturation of Glycosylceramides Paege, Norman Warnecke, Dirk Zäuner, Simone Hagen, Silke Rodrigues, Ana Baumann, Birgit Thiess, Melanie Jung, Sascha Meyer, Vera mSphere Research Article AFP is an antimicrobial peptide (AMP) produced by the filamentous fungus Aspergillus giganteus and is a very potent inhibitor of fungal growth that does not affect the viability of bacteria, plant, or mammalian cells. It targets chitin synthesis and causes plasma membrane permeabilization in many human- and plant-pathogenic fungi, but its exact mode of action is not known. After adoption of the “damage-response framework of microbial pathogenesis” regarding the analysis of interactions between AMPs and microorganisms, we have recently proposed that the cytotoxic capacity of a given AMP depends not only on the presence/absence of its target(s) in the host and the AMP concentration applied but also on other variables, such as microbial survival strategies. We show here using the examples of three filamentous fungi (Aspergillus niger, Aspergillus fumigatus, and Fusarium graminearum) and two yeasts (Saccharomyces cerevisiae and Pichia pastoris) that the important parameters defining the AFP susceptibilities of these fungi are (i) the presence/absence of glycosylceramides, (ii) the presence/absence of Δ3(E) desaturation of the fatty acid chain therein, and (iii) the (dis)ability of these fungi to respond to AFP inhibitory effects with the fortification of their cell walls via increased chitin and β-(1,3)-glucan synthesis. These observations support the idea of the adoption of the damage-response framework to holistically understand the outcome of AFP inhibitory effects. IMPORTANCE Our data suggest a fundamental role of glycosylceramides in the susceptibility of fungi to AFP. We discovered that only a minor structural difference in these molecules—namely, the saturation level of their fatty acid chain, controlled by a 2-hydroxy fatty N-acyl-Δ3(E)-desaturase—represents a key to understanding the inhibitory activity of AFP. As glycosylceramides are important components of fungal plasma membranes, we propose a model which links AFP-mediated inhibition of chitin synthesis in fungi with its potential to disturb plasma membrane integrity. American Society for Microbiology 2019-12-11 /pmc/articles/PMC6908424/ /pubmed/31826973 http://dx.doi.org/10.1128/mSphere.00741-19 Text en Copyright © 2019 Paege et al. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Article
Paege, Norman
Warnecke, Dirk
Zäuner, Simone
Hagen, Silke
Rodrigues, Ana
Baumann, Birgit
Thiess, Melanie
Jung, Sascha
Meyer, Vera
Species-Specific Differences in the Susceptibility of Fungi to the Antifungal Protein AFP Depend on C-3 Saturation of Glycosylceramides
title Species-Specific Differences in the Susceptibility of Fungi to the Antifungal Protein AFP Depend on C-3 Saturation of Glycosylceramides
title_full Species-Specific Differences in the Susceptibility of Fungi to the Antifungal Protein AFP Depend on C-3 Saturation of Glycosylceramides
title_fullStr Species-Specific Differences in the Susceptibility of Fungi to the Antifungal Protein AFP Depend on C-3 Saturation of Glycosylceramides
title_full_unstemmed Species-Specific Differences in the Susceptibility of Fungi to the Antifungal Protein AFP Depend on C-3 Saturation of Glycosylceramides
title_short Species-Specific Differences in the Susceptibility of Fungi to the Antifungal Protein AFP Depend on C-3 Saturation of Glycosylceramides
title_sort species-specific differences in the susceptibility of fungi to the antifungal protein afp depend on c-3 saturation of glycosylceramides
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6908424/
https://www.ncbi.nlm.nih.gov/pubmed/31826973
http://dx.doi.org/10.1128/mSphere.00741-19
work_keys_str_mv AT paegenorman speciesspecificdifferencesinthesusceptibilityoffungitotheantifungalproteinafpdependonc3saturationofglycosylceramides
AT warneckedirk speciesspecificdifferencesinthesusceptibilityoffungitotheantifungalproteinafpdependonc3saturationofglycosylceramides
AT zaunersimone speciesspecificdifferencesinthesusceptibilityoffungitotheantifungalproteinafpdependonc3saturationofglycosylceramides
AT hagensilke speciesspecificdifferencesinthesusceptibilityoffungitotheantifungalproteinafpdependonc3saturationofglycosylceramides
AT rodriguesana speciesspecificdifferencesinthesusceptibilityoffungitotheantifungalproteinafpdependonc3saturationofglycosylceramides
AT baumannbirgit speciesspecificdifferencesinthesusceptibilityoffungitotheantifungalproteinafpdependonc3saturationofglycosylceramides
AT thiessmelanie speciesspecificdifferencesinthesusceptibilityoffungitotheantifungalproteinafpdependonc3saturationofglycosylceramides
AT jungsascha speciesspecificdifferencesinthesusceptibilityoffungitotheantifungalproteinafpdependonc3saturationofglycosylceramides
AT meyervera speciesspecificdifferencesinthesusceptibilityoffungitotheantifungalproteinafpdependonc3saturationofglycosylceramides